Dobson Laura Elizabeth, Prendergast Bernard D
Department of Cardiology, Manchester University NHS Foundation Trust, Manchester, UK.
Department of Cardiology, St Thomas' Hospital, London, UK
Heart. 2022 May;108(10):774-779. doi: 10.1136/heartjnl-2021-320146.
In the centenary year of the British Cardiovascular Society (BCS), this review article outlines the influence of UK cardiologists and surgeons on the field of heart valve disease, many of whom can rightly claim 'world firsts' in the field. From the description of endocarditis as we know it today at the turn of the 20th century, to the first mitral valvotomy, heart valve replacement and invention of the Ross procedure. These advances have transformed the outlook of patients with symptomatic valve disease from palliation and certain death to curative treatment and near normal life expectancy. Transcatheter aortic valve implantation (TAVI) was adopted early in the UK, and thanks to the comprehensive national database, the UK TAVI registry is one of the world's largest, contributing real-world patient data to inform clinical practice. The more recent concepts of 'Heart Valve Centres of Excellence' and specialist valve clinics have been developed by the BCS-affiliated British Heart Valve Society which continues to drive improved standards for patients with heart valve disease. The next 100 years will no doubt be equally thrilling in terms of innovation for heart valve disease, with artificial intelligence, transcatheter therapies and cutting-edge technology continuing to improve patient care and clinical outcomes.
在英国心血管学会（BCS）成立一百周年之际，这篇综述文章概述了英国心脏病专家和外科医生对心脏瓣膜病领域的影响，他们中的许多人在该领域都有资格宣称取得了“世界首创”。从20世纪之交我们如今所熟知的心内膜炎的描述，到首例二尖瓣切开术、心脏瓣膜置换术以及罗斯手术的发明。这些进展已将有症状瓣膜病患者的前景从姑息治疗和必死无疑转变为治愈性治疗以及接近正常的预期寿命。经导管主动脉瓣植入术（TAVI）在英国早期就被采用，并且由于全面的国家数据库，英国TAVI登记处是世界上最大的登记处之一，为临床实践提供真实世界的患者数据。“卓越心脏瓣膜中心”和专科瓣膜诊所等更新的概念由与BCS相关的英国心脏瓣膜学会提出，该学会继续推动提高心脏瓣膜病患者的治疗标准。毫无疑问，在心脏瓣膜病创新方面，未来100年同样令人兴奋，人工智能、经导管治疗和前沿技术将继续改善患者护理和临床结果。
